By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


SEARCH JOBS








Company News
Horizon Pharma (HZNP) Announces Settlement Of PENNSAID (Diclofenac Sodium Topical Solution) 2% W/W Patent Litigation With Amneal 4/25/2016 10:35:20 AM
Horizon Pharma (HZNP) To Host First-Quarter 2016 Conference Call And Webcast On May 9, 2016 4/20/2016 12:03:50 PM
Horizon Pharma (HZNP) Named To Crain's Chicago Business First Ever 2016 4/4/2016 10:54:08 AM
Horizon Pharma (HZNP) Receives Health Canada Approval For RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For The Treatment Of Urea Cycle Disorders In Patients Two Years Of Age And Older 3/21/2016 11:19:56 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAVICTI (Glycerol Phenylbutyrate) Oral Liquid 3/16/2016 10:44:39 AM
Horizon Pharma (HZNP) Raises CEO's Pay 10-Fold to $93.4 Million 3/16/2016 6:26:54 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 3/14/2016 11:36:01 AM
Horizon Pharma (HZNP) To Participate In Cowen and Company 36th Annual Health Care Conference 3/2/2016 11:11:48 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% W/W 3/2/2016 10:42:36 AM
Horizon Pharma (HZNP) Recognizes Rare Disease Community On The "Rarest Day of the Year" 3/1/2016 12:50:12 PM
12345678910...
//-->